Clinical Cohort Study of Knee Arthroplasty Assisted by Digital Technology
Condition(s) studied
Investigational drug(s) / intervention(s)
conventional intrumentation assisted knee arthroplasty: conventional intrumentation assisted knee arthroplasty
computer navigation assisted knee arthroplasty: computer navigation assisted knee arthroplasty
robotic system assisted knee arthroplasty: robotic system assisted knee arthroplasty
patient-spercific assisted knee arthroplasty: patient-spercific assisted knee arthroplasty
Study summary
Through this cohort study, previous clinical data can be systematically reviewed and supplemented through clinical follow-up. Prospective enrollment and follow-up observation of subsequent patients can also be carried out to build a retrospective-prospective two-way cohort study. The intraoperative, perioperative, clinical follow-up and health economics of surgical robot, computer navigation, personalized osteotomy guide and other digital technologies and traditional TKA were comprehensively and objectively compared, the results and conclusions of the center were summarized and reported, and the effectiveness and safety of digital assistive technology applied to TKA were explored, providing references for clinical diagnosis and follow-up research.
Eligibility
Primary outcome measure(s)
- mechanical axis — Postoperative day 3
The postoperative HKA Angle was measured, that is, the Angle between the center of the hip joint and the center of the knee joint and the center of the knee joint and the center of the ankle joint on the full-length X-ray film of the lower limb. The target Angle was defined as 0°, the Angle was positive when the knee was varus, the Angle was negative when the knee was varus, and the acceptable range was ±3°, beyond which the line deviation was defined.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Peking University Third Hospital | Beijing | Beijing Municipality | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06010979 on ClinicalTrials.gov ↗ ← All trials in China